Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2022

Open Access 01-12-2022 | Angiography | Research

Relationship between increased systemic immune-inflammation index and coronary slow flow phenomenon

Authors: Xin-tong Dai, Tian-zhong Kong, Xiao-jiao Zhang, Bo Luan, Yong Wang, Ai-jie Hou

Published in: BMC Cardiovascular Disorders | Issue 1/2022

Login to get access

Abstract

Background

Systemic immune-inflammation index (SII, platelet × neutrophil/lymphocyte ratio), a new marker of inflammation, is associated with adverse cardiovascular events, but its relationship with coronary slow flow phenomenon (CSFP) is unclear. Therefore, we aimed to investigate the relationship between SII and CSFP.

Methods

We enrolled consecutive patients who presented with chest pain, with normal/near-normal coronary angiography findings (n = 89 as CSFP group; n = 167 as control group). The baseline characteristics, laboratory parameters and angiographic characteristics of the two groups were compared.

Results

SII levels were significantly higher in the CSFP group than in the control group (409.7 ± 17.7 vs. 396.7 ± 12.7, p < 0.001). A significant positive correlation between SII and the mean thrombolysis in myocardial infarction frame count (mTFC) was found (r = 0.624, p < 0.001). SII increased with the number of coronary arteries involved in CSFP. In multivariate logistic regression analysis, SII/10 was an independent predictor of CSFP (odds ratio: 1.739, p < 0.001). In addition, the SII level > 404.29 was a predictor of CSFP with 67.4% sensitivity and 71.9% specificity.

Conclusions

SII can predict the occurrence of CSFP.
Literature
1.
go back to reference Beltrame JF. Defining the coronary slow flow phenomenon. Circ J. 2012;76(4):818–20.CrossRef Beltrame JF. Defining the coronary slow flow phenomenon. Circ J. 2012;76(4):818–20.CrossRef
2.
go back to reference Tambe AA, Demany MA, Zimmerman HA, Mascarenhas E. Angina pectoris and slow flow velocity of dye in coronary arteries–a new angiographic finding. Am Heart J. 1972;84(1):66–71.CrossRef Tambe AA, Demany MA, Zimmerman HA, Mascarenhas E. Angina pectoris and slow flow velocity of dye in coronary arteries–a new angiographic finding. Am Heart J. 1972;84(1):66–71.CrossRef
3.
go back to reference Saadat M, Masoudkabir F, Afarideh M, Ghodsi S, Vasheghani-Farahani A: Discrimination between obstructive coronary artery disease and cardiac syndrome X in women with typical angina and positive exercise test; Utility of Cardiovascular Risk Calculators. Medicina (Kaunas, Lithuania) 2019, 55(1). Saadat M, Masoudkabir F, Afarideh M, Ghodsi S, Vasheghani-Farahani A: Discrimination between obstructive coronary artery disease and cardiac syndrome X in women with typical angina and positive exercise test; Utility of Cardiovascular Risk Calculators. Medicina (Kaunas, Lithuania) 2019, 55(1).
4.
go back to reference Kalay N, Aytekin M, Kaya MG, Ozbek K, Karayakalı M, Söğüt E, Altunkas F, Oztürk A, Koç F. The relationship between inflammation and slow coronary flow: increased red cell distribution width and serum uric acid levels. Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir. 2011;39(6):463–8.CrossRef Kalay N, Aytekin M, Kaya MG, Ozbek K, Karayakalı M, Söğüt E, Altunkas F, Oztürk A, Koç F. The relationship between inflammation and slow coronary flow: increased red cell distribution width and serum uric acid levels. Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir. 2011;39(6):463–8.CrossRef
5.
go back to reference Enli Y, Turk M, Akbay R, Evrengul H, Tanriverdi H, Kuru O, Seleci D, Kaftan A, Ozer O, Enli H. Oxidative stress parameters in patients with slow coronary flow. Adv Ther. 2008;25(1):37–44.CrossRef Enli Y, Turk M, Akbay R, Evrengul H, Tanriverdi H, Kuru O, Seleci D, Kaftan A, Ozer O, Enli H. Oxidative stress parameters in patients with slow coronary flow. Adv Ther. 2008;25(1):37–44.CrossRef
6.
go back to reference Beltrame JF, Limaye SB, Horowitz JD. The coronary slow flow phenomenon–a new coronary microvascular disorder. Cardiology. 2002;97(4):197–202.CrossRef Beltrame JF, Limaye SB, Horowitz JD. The coronary slow flow phenomenon–a new coronary microvascular disorder. Cardiology. 2002;97(4):197–202.CrossRef
7.
go back to reference Sezgin AT, Sigirci A, Barutcu I, Topal E, Sezgin N, Ozdemir R, Yetkin E, Tandogan I, Kosar F, Ermis N, et al. Vascular endothelial function in patients with slow coronary flow. Coron Artery Dis. 2003;14(2):155–61.CrossRef Sezgin AT, Sigirci A, Barutcu I, Topal E, Sezgin N, Ozdemir R, Yetkin E, Tandogan I, Kosar F, Ermis N, et al. Vascular endothelial function in patients with slow coronary flow. Coron Artery Dis. 2003;14(2):155–61.CrossRef
8.
go back to reference Cin VG, Pekdemir H, Camsar A, Ciçek D, Akkus MN, Parmaksýz T, Katýrcýbaý T, Döven O. Diffuse intimal thickening of coronary arteries in slow coronary flow. Jpn Heart J. 2003;44(6):907–19.CrossRef Cin VG, Pekdemir H, Camsar A, Ciçek D, Akkus MN, Parmaksýz T, Katýrcýbaý T, Döven O. Diffuse intimal thickening of coronary arteries in slow coronary flow. Jpn Heart J. 2003;44(6):907–19.CrossRef
9.
go back to reference Yang YL, Wu CH, Hsu PF, Chen SC, Huang SS, Chan WL, Lin SJ, Chou CY, Chen JW, Pan JP, et al. Systemic immune-inflammation index (SII) predicted clinical outcome in patients with coronary artery disease. Eur J Clin Invest. 2020;50(5): e13230.CrossRef Yang YL, Wu CH, Hsu PF, Chen SC, Huang SS, Chan WL, Lin SJ, Chou CY, Chen JW, Pan JP, et al. Systemic immune-inflammation index (SII) predicted clinical outcome in patients with coronary artery disease. Eur J Clin Invest. 2020;50(5): e13230.CrossRef
10.
go back to reference Candemir M, Kiziltunç E, Nurkoç S, Şahinarslan A. Relationship between systemic immune-inflammation index (SII) and the severity of stable coronary artery disease. Angiology. 2021;72(6):575–81.CrossRef Candemir M, Kiziltunç E, Nurkoç S, Şahinarslan A. Relationship between systemic immune-inflammation index (SII) and the severity of stable coronary artery disease. Angiology. 2021;72(6):575–81.CrossRef
11.
go back to reference Kelesoglu S, Yilmaz Y, Elcık D, Kalay N: Systemic immune inflammation index: a novel predictor for coronary collateral circulation. Perfusion 2021:2676591211014822. Kelesoglu S, Yilmaz Y, Elcık D, Kalay N: Systemic immune inflammation index: a novel predictor for coronary collateral circulation. Perfusion 2021:2676591211014822.
12.
go back to reference Adali MK, Buber I, Kilic O, Turkoz A, Yilmaz S: Ticagrelor improves systemic immune-inflammation index in acute coronary syndrome patients. Acta cardiologica 2021:1–7. Adali MK, Buber I, Kilic O, Turkoz A, Yilmaz S: Ticagrelor improves systemic immune-inflammation index in acute coronary syndrome patients. Acta cardiologica 2021:1–7.
13.
go back to reference Gibson CM, Cannon CP, Daley WL, Dodge JT Jr, Alexander B Jr, Marble SJ, McCabe CH, Raymond L, Fortin T, Poole WK, et al. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation. 1996;93(5):879–88.CrossRef Gibson CM, Cannon CP, Daley WL, Dodge JT Jr, Alexander B Jr, Marble SJ, McCabe CH, Raymond L, Fortin T, Poole WK, et al. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation. 1996;93(5):879–88.CrossRef
14.
go back to reference Wang Y, Liu MJ, Yang HM, Ma CY, Jia PY, Jia DL, Hou AJ. Association between increased serum alkaline phosphatase and the coronary slow flow phenomenon. BMC Cardiovasc Disord. 2018;18(1):138.CrossRef Wang Y, Liu MJ, Yang HM, Ma CY, Jia PY, Jia DL, Hou AJ. Association between increased serum alkaline phosphatase and the coronary slow flow phenomenon. BMC Cardiovasc Disord. 2018;18(1):138.CrossRef
15.
go back to reference Doğan M, Akyel A, Çimen T, Bilgin M, Sunman H, Kasapkara HA, Arslantaş U, Yayla KG, Açıkel S, Yeter E. Relationship between neutrophil to lymphocyte ratio and slow coronary flow. Clin Appl Thrombosis/Hemostasis. 2015;21(3):251–4.CrossRef Doğan M, Akyel A, Çimen T, Bilgin M, Sunman H, Kasapkara HA, Arslantaş U, Yayla KG, Açıkel S, Yeter E. Relationship between neutrophil to lymphocyte ratio and slow coronary flow. Clin Appl Thrombosis/Hemostasis. 2015;21(3):251–4.CrossRef
16.
go back to reference Yilmaz H, Demir I, Uyar Z. Clinical and coronary angiographic characteristics of patients with coronary slow flow. Acta Cardiol. 2008;63(5):579–84.CrossRef Yilmaz H, Demir I, Uyar Z. Clinical and coronary angiographic characteristics of patients with coronary slow flow. Acta Cardiol. 2008;63(5):579–84.CrossRef
17.
go back to reference Chalikias G, Tziakas D. Slow coronary flow: pathophysiology, clinical implications, and therapeutic management. Angiology. 2021;72(9):808–18.CrossRef Chalikias G, Tziakas D. Slow coronary flow: pathophysiology, clinical implications, and therapeutic management. Angiology. 2021;72(9):808–18.CrossRef
18.
go back to reference Barutcu I, Sezgin AT, Sezgin N, Gullu H, Esen AM, Topal E, Ozdemir R, Kosar F, Cehreli S. Increased high sensitive CRP level and its significance in pathogenesis of slow coronary flow. Angiology. 2007;58(4):401–7.CrossRef Barutcu I, Sezgin AT, Sezgin N, Gullu H, Esen AM, Topal E, Ozdemir R, Kosar F, Cehreli S. Increased high sensitive CRP level and its significance in pathogenesis of slow coronary flow. Angiology. 2007;58(4):401–7.CrossRef
19.
go back to reference Şatıroğlu Ö, Durakoğlugil ME, Çetin M, Çiçek Y, Erdoğan T, Duman H. The role of urotensin II and atherosclerotic risk factors in patients with slow coronary flow. Intervent Med Appl Sci. 2016;8(4):158–63.CrossRef Şatıroğlu Ö, Durakoğlugil ME, Çetin M, Çiçek Y, Erdoğan T, Duman H. The role of urotensin II and atherosclerotic risk factors in patients with slow coronary flow. Intervent Med Appl Sci. 2016;8(4):158–63.CrossRef
20.
go back to reference Erdogan D, Caliskan M, Gullu H, Sezgin AT, Yildirir A, Muderrisoglu H. Coronary flow reserve is impaired in patients with slow coronary flow. Atherosclerosis. 2007;191(1):168–74.CrossRef Erdogan D, Caliskan M, Gullu H, Sezgin AT, Yildirir A, Muderrisoglu H. Coronary flow reserve is impaired in patients with slow coronary flow. Atherosclerosis. 2007;191(1):168–74.CrossRef
21.
go back to reference Tanriverdi H, Evrengul H, Enli Y, Kuru O, Seleci D, Tanriverdi S, Tuzun N, Kaftan HA, Karabulut N. Effect of homocysteine-induced oxidative stress on endothelial function in coronary slow-flow. Cardiology. 2007;107(4):313–20.CrossRef Tanriverdi H, Evrengul H, Enli Y, Kuru O, Seleci D, Tanriverdi S, Tuzun N, Kaftan HA, Karabulut N. Effect of homocysteine-induced oxidative stress on endothelial function in coronary slow-flow. Cardiology. 2007;107(4):313–20.CrossRef
22.
go back to reference Akboga MK, Canpolat U, Balci KG, Akyel A, Sen F, Yayla C, Cay S, Aras D, Aydogdu S. Increased platelet to lymphocyte ratio is related to slow coronary flow. Angiology. 2016;67(1):21–6.CrossRef Akboga MK, Canpolat U, Balci KG, Akyel A, Sen F, Yayla C, Cay S, Aras D, Aydogdu S. Increased platelet to lymphocyte ratio is related to slow coronary flow. Angiology. 2016;67(1):21–6.CrossRef
23.
go back to reference Sanati H, Kiani R, Shakerian F, Firouzi A, Zahedmehr A, Peighambari M, Shokrian L, Ashrafi P. Coronary slow flow phenomenon clinical findings and predictors. Res Cardiovasc Med. 2016;5(1): e30296.CrossRef Sanati H, Kiani R, Shakerian F, Firouzi A, Zahedmehr A, Peighambari M, Shokrian L, Ashrafi P. Coronary slow flow phenomenon clinical findings and predictors. Res Cardiovasc Med. 2016;5(1): e30296.CrossRef
24.
go back to reference Aciksari G, Cetinkal G, Kocak M, Atici A, Celik FB, Caliskan M. The relationship between triglyceride/high-density lipoprotein cholesterol ratio and coronary slow-flow phenomenon. Int J Cardiovasc Imaging. 2022;38(1):5–13.CrossRef Aciksari G, Cetinkal G, Kocak M, Atici A, Celik FB, Caliskan M. The relationship between triglyceride/high-density lipoprotein cholesterol ratio and coronary slow-flow phenomenon. Int J Cardiovasc Imaging. 2022;38(1):5–13.CrossRef
25.
go back to reference Xia S, Deng SB, Wang Y, Xiao J, Du JL, Zhang Y, Wang XC, Li YQ, Zhao R, He L, et al. Clinical analysis of the risk factors of slow coronary flow. Heart Vessels. 2011;26(5):480–6.CrossRef Xia S, Deng SB, Wang Y, Xiao J, Du JL, Zhang Y, Wang XC, Li YQ, Zhao R, He L, et al. Clinical analysis of the risk factors of slow coronary flow. Heart Vessels. 2011;26(5):480–6.CrossRef
26.
go back to reference Balta S, Celik T, Mikhailidis DP, Ozturk C, Demirkol S, Aparci M, Iyisoy A. The relation between atherosclerosis and the neutrophil-lymphocyte ratio. Clin Appl thrombosis/hemostasis. 2016;22(5):405–11.CrossRef Balta S, Celik T, Mikhailidis DP, Ozturk C, Demirkol S, Aparci M, Iyisoy A. The relation between atherosclerosis and the neutrophil-lymphocyte ratio. Clin Appl thrombosis/hemostasis. 2016;22(5):405–11.CrossRef
27.
go back to reference Döring Y, Soehnlein O, Weber C. Neutrophil extracellular traps in atherosclerosis and atherothrombosis. Circ Res. 2017;120(4):736–43.CrossRef Döring Y, Soehnlein O, Weber C. Neutrophil extracellular traps in atherosclerosis and atherothrombosis. Circ Res. 2017;120(4):736–43.CrossRef
28.
go back to reference Tosu AR, Biter H. Association of systemic immune-inflammation index (SII) with presence of isolated coronary artery ectasia. Arch Med Sci Atherosclerot Dis. 2021;6:e152–7.CrossRef Tosu AR, Biter H. Association of systemic immune-inflammation index (SII) with presence of isolated coronary artery ectasia. Arch Med Sci Atherosclerot Dis. 2021;6:e152–7.CrossRef
29.
go back to reference Thomson SP, McMahon LJ, Nugent CA. Endogenous cortisol: a regulator of the number of lymphocytes in peripheral blood. Clin Immunol Immunopathol. 1980;17(4):506–14.CrossRef Thomson SP, McMahon LJ, Nugent CA. Endogenous cortisol: a regulator of the number of lymphocytes in peripheral blood. Clin Immunol Immunopathol. 1980;17(4):506–14.CrossRef
30.
go back to reference Erdoğan M, Erdöl MA, Öztürk S, Durmaz T. Systemic immune-inflammation index is a novel marker to predict functionally significant coronary artery stenosis. Biomark Med. 2020;14(16):1553–61.CrossRef Erdoğan M, Erdöl MA, Öztürk S, Durmaz T. Systemic immune-inflammation index is a novel marker to predict functionally significant coronary artery stenosis. Biomark Med. 2020;14(16):1553–61.CrossRef
31.
go back to reference Major AS, Fazio S, Linton MF. B-lymphocyte deficiency increases atherosclerosis in LDL receptor-null mice. Arterioscler Thromb Vasc Biol. 2002;22(11):1892–8.CrossRef Major AS, Fazio S, Linton MF. B-lymphocyte deficiency increases atherosclerosis in LDL receptor-null mice. Arterioscler Thromb Vasc Biol. 2002;22(11):1892–8.CrossRef
32.
go back to reference Núñez J, Miñana G, Bodí V, Núñez E, Sanchis J, Husser O, Llàcer A. Low lymphocyte count and cardiovascular diseases. Curr Med Chem. 2011;18(21):3226–33.CrossRef Núñez J, Miñana G, Bodí V, Núñez E, Sanchis J, Husser O, Llàcer A. Low lymphocyte count and cardiovascular diseases. Curr Med Chem. 2011;18(21):3226–33.CrossRef
33.
go back to reference Gawaz M, Langer H, May AE. Platelets in inflammation and atherogenesis. J Clin Investig. 2005;115(12):3378–84.CrossRef Gawaz M, Langer H, May AE. Platelets in inflammation and atherogenesis. J Clin Investig. 2005;115(12):3378–84.CrossRef
34.
go back to reference Celik T, Yuksel UC, Bugan B, Iyisoy A, Celik M, Demirkol S, Yaman H, Kursaklioglu H, Kilic S, Isik E. Increased platelet activation in patients with slow coronary flow. J Thromb Thrombolysis. 2010;29(3):310–5.CrossRef Celik T, Yuksel UC, Bugan B, Iyisoy A, Celik M, Demirkol S, Yaman H, Kursaklioglu H, Kilic S, Isik E. Increased platelet activation in patients with slow coronary flow. J Thromb Thrombolysis. 2010;29(3):310–5.CrossRef
35.
go back to reference Avşar O, Demir I, Ekiz O, Altekin RE, Yalçinkaya S. Relationship between the slow coronary flow and carotid artery intima-media thickness. Anadolu kardiyoloji dergisi AKD Anatol J Cardiol. 2007;7(1):19–23. Avşar O, Demir I, Ekiz O, Altekin RE, Yalçinkaya S. Relationship between the slow coronary flow and carotid artery intima-media thickness. Anadolu kardiyoloji dergisi AKD Anatol J Cardiol. 2007;7(1):19–23.
36.
go back to reference Kaya H, Ertaş F, İslamoğlu Y, Kaya Z, Atılgan ZA, Çil H, Çalışkan A, Aydın M, Oylumlu M, Soydinç MS. Association between neutrophil to lymphocyte ratio and severity of coronary artery disease. Clin Appl Thrombosis/Hemostasis. 2014;20(1):50–4.CrossRef Kaya H, Ertaş F, İslamoğlu Y, Kaya Z, Atılgan ZA, Çil H, Çalışkan A, Aydın M, Oylumlu M, Soydinç MS. Association between neutrophil to lymphocyte ratio and severity of coronary artery disease. Clin Appl Thrombosis/Hemostasis. 2014;20(1):50–4.CrossRef
Metadata
Title
Relationship between increased systemic immune-inflammation index and coronary slow flow phenomenon
Authors
Xin-tong Dai
Tian-zhong Kong
Xiao-jiao Zhang
Bo Luan
Yong Wang
Ai-jie Hou
Publication date
01-12-2022
Publisher
BioMed Central
Keyword
Angiography
Published in
BMC Cardiovascular Disorders / Issue 1/2022
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/s12872-022-02798-0

Other articles of this Issue 1/2022

BMC Cardiovascular Disorders 1/2022 Go to the issue